Cargando…
Removal of Hepatitis C Virus-Infected Cells by a Zymogenized Bacterial Toxin
Hepatitis C virus (HCV) infection is a major cause of chronic liver disease and has become a global health threat. No HCV vaccine is currently available and treatment with antiviral therapy is associated with adverse side effects. Moreover, there is no preventive therapy for recurrent hepatitis C po...
Autores principales: | Shapira, Assaf, Shapira, Shiran, Gal-Tanamy, Meital, Zemel, Romy, Tur-Kaspa, Ran, Benhar, Itai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3281143/ https://www.ncbi.nlm.nih.gov/pubmed/22359682 http://dx.doi.org/10.1371/journal.pone.0032320 |
Ejemplares similares
-
Engineered Toxins “Zymoxins” Are Activated by the HCV NS3 Protease by Removal of an Inhibitory Protein Domain
por: Shapira, Assaf, et al.
Publicado: (2011) -
Toxin-Based Therapeutic Approaches
por: Shapira, Assaf, et al.
Publicado: (2010) -
25-Hydroxyvitamin D Inhibits Hepatitis C Virus Production in Hepatocellular Carcinoma Cell Line by a Vitamin D Receptor-Independent Mechanism
por: Ravid, Amiram, et al.
Publicado: (2019) -
Selective eradication of cancer cells by delivery of adenovirus-based toxins
por: Shapira, Shiran, et al.
Publicado: (2017) -
Pancreatic cancer in bloom syndrome
por: Tzfoni, Itai, et al.
Publicado: (2019)